M1A.2
Drug-induced chronic gout
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced chronic gout, classified under ICD-10 Code M1A.2, is a long-term form of gout that develops as a result of certain medications. This condition involves the buildup of uric acid crystals in the joints, leading to persistent inflammation, pain, and joint damage. Unlike acute gout attacks, which occur suddenly and resolve with treatment, chronic gout persists over time and requires ongoing management to prevent joint deterioration.
Causes & Symptoms
Clinical Causes: Use of medications that elevate uric acid levels, such as thiazide diuretics, loop diuretics, or aspirin in high doses Long-term consumption of medications that interfere with uric acid excretion by the kidneys Underlying health conditions that, combined with medication effects, increase uric acid accumulation
Key Symptoms: Persistent joint pain, especially in the big toe, ankles, knees, or wrists Swelling and warmth in affected joints Frequent outbreaks of joint inflammation lasting days or weeks Presence of tophi, which are deposits of uric acid crystals under the skin Limited joint mobility due to chronic inflammation and damage
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. A doctor may perform joint fluid analysis to detect uric acid crystals and blood tests to measure uric acid levels. Imaging studies like X-rays can reveal joint damage and tophi, supporting the diagnosis of chronic gout. It’s important to review medication history to identify drugs contributing to the condition.
Treatment Protocols: Management of drug-induced chronic gout focuses on reducing uric acid levels and controlling joint inflammation. Approaches include: - Discontinuing or switching medications that elevate uric acid, under medical supervision - Use of uric acid-lowering drugs such as allopurinol or febuxostat - Anti-inflammatory medications to manage pain and swelling during gout attacks - Lifestyle modifications including dietary changes to reduce purine intake, maintaining hydration, and avoiding alcohol - Regular monitoring of uric acid levels to guide treatment adjustments A healthcare provider can develop a personalized treatment plan to help minimize symptoms and prevent joint damage.
Clinical Advice & FAQs
Billing Guidance
Is M1A.2 a billable ICD-10 code?
Yes, M1A.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.2?
Clinical documentation must specify the nature of Drug-induced chronic gout and any associated comorbidities for accurate reporting.
Cite this Clinical Reference